Alexander Sigalov

Principal investigator.

BiotechORCID
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$1.4MFederal grants as PI6 awards
1Patents grantedLatest Sep 23, 2025
87Papers1,667 citations
Career record

Federal awards and patents by year

20152025
AwardsPatents
Federal awards as principal investigator

6 awards · $1.4M

DateAgencyAwardAmountCompany
Sep 10, 2020NIHSBIR Phase I
TREM-1 inhibitor for the treatment of scleroderma
$250KSIGNABLOK, INC.
Sep 9, 2020NIHSBIR Phase I
TREM-1 therapy for rheumatoid arthritis
$259KSIGNABLOK, INC.
Sep 1, 2018NIHSBIR Phase I
Novel TREM-1 targeting therapies for sepsis
$225KSIGNABLOK, INC.
Jun 1, 2018NIHSBIR Phase I
Development of first-in-class TREM-1 inhibitors for neovascular retinal diseases
$226KSIGNABLOK, INC.
Sep 5, 2016NIHSBIR Phase I
Treatment of alcoholic liver disease with novel targeted inhibitors
$223KSIGNABLOK, INC.
Aug 18, 2015NIHSBIR Phase I
Development of novel targeted agents in pancreatic cancer
$220KSIGNABLOK, INC.
Patents

2 patents as inventor

Matched by the first inventor’s name and the patent’s company.

Among 4,078 researchers in Biotech

Peer ranks

Federal funding#1,463
Awards as PI#315
Patents#155
From filings, awards and patents

Companies

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.